Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 08, 2026 08:00 ET | Source: Remedy Plan Therapeutics

Remedy Plan Therapeutics Appoints Jotin Marango, M.D., Ph.D., as Chief Financial and Business Officer

GAITHERSBURG, Md., April 08, 2026 (GLOBE NEWSWIRE) -- Remedy Plan Therapeutics, a clinical-stage biotechnology company developing novel therapies that target fundamental metabolic vulnerabilities in...
April 08, 2026 08:00 ET | Source: Lifecore Biomedical, Inc.

Lifecore Biomedical to Participate at 12th Annual American Biomanufacturing Summit

Lifecore Biomedical to Participate at 12th Annual American Biomanufacturing Summit
April 08, 2026 08:00 ET | Source: Artiva Biotherapeutics, Inc.

Artiva Biotherapeutics to Participate in the 25th Annual Needham Virtual Healthcare Conference

Artiva Biotherapeutics to Participate in the 25th Annual Needham Virtual Healthcare Conference
April 08, 2026 07:00 ET | Source: Climb Bio, Inc.

Climb Bio to Host R&D Spotlight Webcast Highlighting Budoprutug and the CD19 Opportunity on May 5, 2026

WELLESLEY HILLS, Mass., April 08, 2026 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today...
April 08, 2026 07:00 ET | Source: Immusoft

Immusoft Announces Presentation of World's First Patient Treated with an Engineered B Cell Therapy at Workshop Co-Hosted by FDA and ARM

SAN FRANCISCO, April 08, 2026 (GLOBE NEWSWIRE) -- Immusoft of CA, a clinical-stage biotechnology company pioneering engineered B cell therapies, today announced that it will present an invited...
April 08, 2026 07:00 ET | Source: TScan Therapeutics, Inc.

TScan Therapeutics to Participate in the 25th Annual Needham Virtual Healthcare Conference

WALTHAM, Mass., April 08, 2026 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T...
April 08, 2026 06:50 ET | Source: ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet

PRINCETON, N.J., April 08, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that following final approval from the U.S. Food and Drug...
April 08, 2026 06:00 ET | Source: AtaiBeckley Inc.

AtaiBeckley’s BPL-003 Shows Rapid, Durable Antidepressant Response in Treatment-Resistant Depression Patients on SSRIs; Phase 2a Data Published in CNS Drugs

66.7% of participants achieved an antidepressant response by Day 2 following a single intranasal dose of BPL-003 in both the 10 mg (n=6) and 12 mg (n=6) cohortsDurable responses observed at Day 85:...
April 08, 2026 05:17 ET | Source: Research and Markets

Pharmacovigilance Market - Global Forecast 2026-2032: Increased Collaboration Across Sectors Present New Challenges and Opportunities for Patient Safety and Compliance

Dublin, April 08, 2026 (GLOBE NEWSWIRE) -- The "Pharmacovigilance Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. The Pharmacovigilance Market...
April 08, 2026 03:00 ET | Source: Aravax

Aravax Strengthens Board with Appointments of Carsten Hellmann and Andrew Oxtoby

MELBOURNE, Australia and OXFORD, United Kingdom, April 08, 2026 (GLOBE NEWSWIRE) -- Aravax, a clinical-stage biotechnology company developing next-generation, disease-modifying immunotherapies for...